{"id":"https://openalex.org/W7223103992","doi":"https://doi.org/10.1016/j.htct.2026.107811","title":"PREDICTIVE VALUE OF INTEGRATING CIRCULATING TUMOR DNA AND END-OF-TREATMENT PET/CT FOR RELAPSE PREDICTION IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED AT A REFERRAL CENTER","display_name":"PREDICTIVE VALUE OF INTEGRATING CIRCULATING TUMOR DNA AND END-OF-TREATMENT PET/CT FOR RELAPSE PREDICTION IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED AT A REFERRAL CENTER","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7223103992","doi":"https://doi.org/10.1016/j.htct.2026.107811"},"language":"en","primary_location":{"id":"doi:10.1016/j.htct.2026.107811","doi":"https://doi.org/10.1016/j.htct.2026.107811","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107811","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2531137926015580/pdf","source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.sciencedirect.com/science/article/pii/S2531137926015580/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049519774","display_name":"Christopher Cralcev","orcid":"https://orcid.org/0009-0005-0266-610X","observed_orcids":["https://orcid.org/0009-0005-0266-610X"]},"institutions":[{"id":"https://openalex.org/I181391015","display_name":"Universidade Estadual de Campinas (UNICAMP)","ror":"https://ror.org/04wffgt70","country_code":"BR","type":"education","lineage":["https://openalex.org/I181391015"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Christopher CRALCEV","raw_affiliation_strings":["Centro de Hematologia e Hemoterapia (Hemocentro), Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Hematologia e Hemoterapia (Hemocentro), Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brasil","institution_ids":["https://openalex.org/I181391015"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071763718","display_name":"Guilherme Duffles","orcid":"https://orcid.org/0000-0002-6058-7558","observed_orcids":["https://orcid.org/0000-0002-6058-7558"]},"institutions":[{"id":"https://openalex.org/I181391015","display_name":"Universidade Estadual de Campinas (UNICAMP)","ror":"https://ror.org/04wffgt70","country_code":"BR","type":"education","lineage":["https://openalex.org/I181391015"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Guilherme DUFFLES","raw_affiliation_strings":["Centro de Hematologia e Hemoterapia (Hemocentro), Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Hematologia e Hemoterapia (Hemocentro), Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brasil","institution_ids":["https://openalex.org/I181391015"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159201363","display_name":"Jersey Heitor Silva MAU\u00c9S","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181391015","display_name":"Universidade Estadual de Campinas (UNICAMP)","ror":"https://ror.org/04wffgt70","country_code":"BR","type":"education","lineage":["https://openalex.org/I181391015"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Jersey Heitor Silva MAU\u00c9S","raw_affiliation_strings":["Centro de Hematologia e Hemoterapia (Hemocentro), Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Hematologia e Hemoterapia (Hemocentro), Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brasil","institution_ids":["https://openalex.org/I181391015"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003822369","display_name":"Fernanda C. S. Lupinacci","orcid":"https://orcid.org/0000-0001-6217-9892","observed_orcids":["https://orcid.org/0000-0001-6217-9892"]},"institutions":[{"id":"https://openalex.org/I4210148096","display_name":"Fleury S.A. (Brazil)","ror":"https://ror.org/04q9me654","country_code":"BR","type":"company","lineage":["https://openalex.org/I4210148096"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Fernanda LUPINACCI","raw_affiliation_strings":["Fleury Medicina e Sa\u00fade, S\u00e3o Paulo, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fleury Medicina e Sa\u00fade, S\u00e3o Paulo, SP, Brasil","institution_ids":["https://openalex.org/I4210148096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159188681","display_name":"Luciana GUILHERMINO PEREIRA","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148096","display_name":"Fleury S.A. (Brazil)","ror":"https://ror.org/04q9me654","country_code":"BR","type":"company","lineage":["https://openalex.org/I4210148096"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Luciana GUILHERMINO PEREIRA","raw_affiliation_strings":["Fleury Medicina e Sa ude , S\u00e3o Paulo , SP , Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fleury Medicina e Sa ude , S\u00e3o Paulo , SP , Brasil","institution_ids":["https://openalex.org/I4210148096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159218315","display_name":"Elisa NAPOLITANO FERREIRA","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148096","display_name":"Fleury S.A. (Brazil)","ror":"https://ror.org/04q9me654","country_code":"BR","type":"company","lineage":["https://openalex.org/I4210148096"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Elisa NAPOLITANO FERREIRA","raw_affiliation_strings":["Fleury Medicina e Sa ude , S\u00e3o Paulo , SP , Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fleury Medicina e Sa ude , S\u00e3o Paulo , SP , Brasil","institution_ids":["https://openalex.org/I4210148096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159208641","display_name":"Fernanda SOARES NIEMANN","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181391015","display_name":"Universidade Estadual de Campinas (UNICAMP)","ror":"https://ror.org/04wffgt70","country_code":"BR","type":"education","lineage":["https://openalex.org/I181391015"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Fernanda SOARES NIEMANN","raw_affiliation_strings":["Centro de Hematologia e Hemoterapia (Hemocentro) , Universidade Estadual de Campinas (UNICAMP) , Campinas , SP , Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Hematologia e Hemoterapia (Hemocentro) , Universidade Estadual de Campinas (UNICAMP) , Campinas , SP , Brasil","institution_ids":["https://openalex.org/I181391015"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159165482","display_name":"Maria Emilia SEREN TAKAHASHI","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Emilia SEREN TAKAHASHI","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159214285","display_name":"Celso DAR\u00cdO RAMOS","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Celso DAR\u00cdO RAMOS","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159181171","display_name":"Maria Lourdes L. FERRARI CHAUFFAILLE","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Lourdes L. FERRARI CHAUFFAILLE","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5087059063","display_name":"Irene Lorand- Metze","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181391015","display_name":"Universidade Estadual de Campinas (UNICAMP)","ror":"https://ror.org/04wffgt70","country_code":"BR","type":"education","lineage":["https://openalex.org/I181391015"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Irene LORAND-METZE","raw_affiliation_strings":["Centro de Hematologia e Hemoterapia (Hemocentro), Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Hematologia e Hemoterapia (Hemocentro), Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brasil","institution_ids":["https://openalex.org/I181391015"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":0,"currency":"USD","value_usd":0},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.84118375,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"48","issue":null,"first_page":"107811","last_page":"107811"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/circulating-tumor-dna","display_name":"circulating tumor DNA","score":0.9990000128746033},{"id":"https://openalex.org/keywords/liquid-biopsy","display_name":"liquid biopsy","score":0.7070000171661377},{"id":"https://openalex.org/keywords/fdg-pet-ct","display_name":"FDG PET/CT","score":0.8550000190734863},{"id":"https://openalex.org/keywords/recurrence-prediction","display_name":"recurrence prediction","score":0.8479999899864197},{"id":"https://openalex.org/keywords/treatment-response-assessment","display_name":"treatment response assessment","score":0.5879999995231628},{"id":"https://openalex.org/keywords/molecular-residual-disease","display_name":"molecular residual disease","score":0.7360000014305115},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7049999833106995},{"id":"https://openalex.org/keywords/chemoimmunotherapy","display_name":"chemoimmunotherapy","score":0.8360000252723694},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.7440000176429749},{"id":"https://openalex.org/keywords/germinal-center-b-cell-like","display_name":"germinal center B-cell-like","score":0.6800000071525574},{"id":"https://openalex.org/keywords/activated-b-cell-like","display_name":"activated B-cell-like","score":0.9890000224113464},{"id":"https://openalex.org/keywords/cell-of-origin","display_name":"cell of origin","score":0.5580000281333923},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.3720000088214874}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9559999704360962},{"id":"https://openalex.org/C3019719930","wikidata":"https://www.wikidata.org/wiki/Q3910099","display_name":"Predictive value","level":2,"score":0.7745000123977661},{"id":"https://openalex.org/C2781335228","wikidata":"https://www.wikidata.org/wiki/Q19596321","display_name":"Circulating tumor DNA","level":3,"score":0.7020000219345093},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6656000018119812},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6525999903678894},{"id":"https://openalex.org/C2776135927","wikidata":"https://www.wikidata.org/wiki/Q5242559","display_name":"Referral","level":2,"score":0.5935999751091003},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5267999768257141},{"id":"https://openalex.org/C2779463800","wikidata":"https://www.wikidata.org/wiki/Q5062222","display_name":"Center (category theory)","level":2,"score":0.4968000054359436},{"id":"https://openalex.org/C61238886","wikidata":"https://www.wikidata.org/wiki/Q5121689","display_name":"Circulating tumor cell","level":4,"score":0.4862000048160553},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.3971000015735626},{"id":"https://openalex.org/C198433322","wikidata":"https://www.wikidata.org/wiki/Q3910099","display_name":"Predictive value of tests","level":2,"score":0.37369999289512634},{"id":"https://openalex.org/C2776291640","wikidata":"https://www.wikidata.org/wiki/Q2912517","display_name":"Value (mathematics)","level":2,"score":0.3668999969959259},{"id":"https://openalex.org/C2780521871","wikidata":"https://www.wikidata.org/wiki/Q7239671","display_name":"Predictive marker","level":3,"score":0.35690000653266907},{"id":"https://openalex.org/C2780073493","wikidata":"https://www.wikidata.org/wiki/Q7523837","display_name":"Single Center","level":2,"score":0.33959999680519104},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.25060001015663147}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.htct.2026.107811","doi":"https://doi.org/10.1016/j.htct.2026.107811","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107811","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2531137926015580/pdf","source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:135b3d7fc90347caa41cfc101b1338fc","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/135b3d7fc90347caa41cfc101b1338fc","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hematology, Transfusion and Cell Therapy, Vol 48, Iss , Pp 107811- (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.htct.2026.107811","doi":"https://doi.org/10.1016/j.htct.2026.107811","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107811","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2531137926015580/pdf","source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223103992.pdf","grobid_xml":"https://content.openalex.org/works/W7223103992.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W6959046500","https://openalex.org/W4310126611","https://openalex.org/W7162628887","https://openalex.org/W4416756672","https://openalex.org/W4410600851","https://openalex.org/W4417009625","https://openalex.org/W4281690269","https://openalex.org/W4414078314","https://openalex.org/W4402679632","https://openalex.org/W4380077884"],"abstract_inverted_index":{"Background":[0],"Diffuse":[1],"large":[2,28],"B-Cell":[3],"lymphoma":[4,13,30],"(DLBCL)":[5],"is":[6,18],"the":[7,19,69,77,125,175,208,244,293,296,323,344,356,376,385,404],"most":[8],"common":[9],"type":[10],"of":[11,41,62,79,177,216,240,266,282,295,366,378,387,406],"non-Hodgkin\u2019s":[12],"(NHL).":[14],"End-of-treatment":[15],"(EOT)":[16],"FDG-PET/CT":[17],"standard":[20],"imaging":[21],"modality":[22],"for":[23,55,129,160,375],"response":[24,92,168],"assessment":[25,93,169,377],"in":[26,81,124,138,207,313,332,348,359,396],"diffuse":[27],"B-cell":[29],"(DLBCL);":[31],"however,":[32],"its":[33,409],"ability":[34],"to":[35,122,243,320],"accurately":[36],"identify":[37],"patients":[38,82,101,117,179,204,267,300,379,397],"at":[39,76,105,214],"risk":[40],"relapse":[42,288],"remains":[43],"limited.":[44],"Circulating":[45],"tumor":[46],"DNA":[47],"(ctDNA)":[48],"has":[49],"emerged":[50],"as":[51,86,88,252,411],"a":[52,153,211,220,269,279,326,372,400,412],"promising":[53],"biomarker":[54],"disease":[56,228,235],"burden,":[57],"treatment":[58,80,136,151,167],"response,":[59,271,402],"and":[60,75,97,111,147,166,197,219,231,248,257,315,336,355,368],"detection":[61],"molecular":[63],"residual":[64],"disease.":[65,277],"Aim":[66],"To":[67],"evaluate":[68],"correlation":[70],"between":[71,108],"ctDNA":[72,131,161,369,392],"levels":[73],"before":[74,135],"end":[78,176,294],"diagnosed":[83,100],"with":[84,91,102,210,343,380,403],"DLBCL,":[85],"well":[87],"their":[89],"association":[90],"by":[94,352],"PET/CT.":[95],"Materials":[96],"methods":[98],"Newly":[99],"DLBCL":[103],"treated":[104],"our":[106],"institution":[107],"October":[109],"2018":[110],"November":[112],"2021":[113],"were":[114,133,170,180,205,250,312],"included.":[115],"All":[116],"provided":[118],"written":[119],"informed":[120],"consent":[121],"participate":[123],"study.":[126],"Blood":[127],"samples":[128],"plasma":[130],"analysis":[132,162],"collected":[134,159],"(ctDNA1)":[137],"dedicated":[139],"DNA-stabilizing":[140],"blood":[141,156],"collection":[142],"tubes.":[143],"Patients":[144],"underwent":[145],"chemoimmunotherapy,":[146],"eight":[148],"weeks":[149],"after":[150,289],"completion,":[152],"second":[154],"peripheral":[155],"sample":[157],"was":[158,330],"(ctDNA2).":[163],"Disease":[164],"staging":[165],"performed":[171],"using":[172],"FDG-PET/CT.":[173],"At":[174,292],"treatment,":[178,264],"categorized":[181],"into":[182],"four":[183],"groups:":[184],"1)":[185],"PET/CT-negative":[186,190],"/":[187,191,195,200],"ctDNA2-negative;":[188,196],"2)":[189],"ctDNA2-positive;":[192],"3)":[193],"PET/CT-positive":[194,199],"4)":[198],"ctDNA2-positive.":[201],"Results":[202],"Eighteen":[203],"included":[206],"study,":[209],"median":[212,280],"age":[213],"diagnosis":[215],"59":[217],"years":[218],"female":[221],"predominance":[222],"(55.6%).":[223],"Overall,":[224],"36.4%":[225],"had":[226,233,274,302,307],"localized":[227],"(stage":[229,236],"I/II)":[230],"63.6%":[232],"advanced-stage":[234],"IV).":[237],"Regarding":[238],"cell":[239],"origin,":[241],"according":[242],"Hans":[245],"algorithm,":[246],"38.9%":[247],"44.4%":[249],"classified":[251],"germinal":[253],"center":[254],"B-cell\u2013like":[255,259],"(GCB)":[256],"activated":[258],"(ABC),":[260],"respectively.":[261],"Following":[262],"first-line":[263],"83%":[265],"achieved":[268],"complete":[270,401],"whereas":[272,310],"11%":[273],"primary":[275],"refractory":[276],"With":[278],"follow-up":[281,395],"58":[283],"months,":[284],"one":[285],"patient":[286],"experienced":[287],"13":[290],"months.":[291],"observation":[297],"period,":[298],"seven":[299],"(38%)":[301],"died;":[303],"among":[304],"them,":[305],"two":[306],"relapsed":[308],"disease,":[309],"five":[311],"remission":[314],"died":[316],"from":[317],"causes":[318],"unrelated":[319],"lymphoma.":[321],"Among":[322],"evaluated":[324],"groups,":[325],"statistically":[327],"significant":[328],"difference":[329],"observed":[331,347],"both":[333],"progression-free":[334],"survival":[335,338],"overall":[337],"curves":[339],"(p":[340],"<":[341],"0.001),":[342],"best":[345],"outcomes":[346,358],"group":[349,353,360],"2,":[350],"followed":[351],"1,":[354],"worst":[357],"4.":[361],"Conclusion":[362],"The":[363],"combined":[364],"use":[365],"PET/CT":[367],"may":[370],"represent":[371],"useful":[373],"tool":[374],"DLBCL.":[381],"These":[382],"findings":[383],"highlight":[384],"importance":[386],"further":[388],"studies":[389],"evaluating":[390],"longitudinal":[391],"dynamics":[393],"during":[394],"who":[398],"achieve":[399],"aim":[405],"better":[407],"defining":[408],"role":[410],"prognostic":[413],"biomarker.":[414]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-10-22T00:00:00"}